Antimicrobial resistance (AMR) is a leading cause of death around the world, with the highest burdens in low-resource settings, and is expected to grow exponentially to cause around 10 million deaths annually in 2050. It is defined by high degrees of complexity given its international, multisectoral, ‘one health’ and ‘creeping’ features, which creates significant challenges for good governance. In addition, only 0,5% of all AMR related research comes from the social sciences, which indicates that we know relatively little about the behavioral and institutional aspects of antibiotics.